BioMelbourne Network Progressing BioIndustry
9th May BioBriefing - 'Rethinking Your Patent Strategy'
Held at Davies Collison Cave with speakers Mr Michael Caine, Dr Bill Pickering and Dr Tania Obranovich. More
Victorian BioPortal
Looking for Something?
The Victorian BioPortal is the largest online search engine for biotechnology in Victorian with over 2,000 individual listings.
BioMelbourne Network
“The BioMelbourne Network does not guarantee you success, but it does guarantee a reliable thoughtful partner on your journey up a cliff face. The Network's regular sessions, focussed workshops, media presence and personalised services have given Sienna a wealth of wide-ranging contacts and resources to make more confident, smarter decisions in taking its business forward.”
Kerry Hegarty | Managing Director - Sienna Cancer Diagnostics Ltd
SYNkinase Licensing a Pan-Kinase Binding Agent from Garvan and Cancer Therapeutics CRC Pty Ltd
17th May, 2013
SYNkinase Pty Ltd has signed a licence agreement with the Garvan Insitute ofMedical Research and Cancer Therapeutics CRC Pty Ltd to develop and market aunique Pan-Kinase Binding Agent to help screen human cells and tissues andidentify potential drug targets in diseased states.
The novel agent has the unique ability to detect most protein kinases critical cellsignalling proteins... read more…
5 Years of Women in Biotech Sharing Lunch
16th May 2013 Anita Petris, Program Manager BioMelbourne Network.
Many a project is conceived or deal signed over a cup of coffee or a glass of wine. So it was with the inception of the BioMelbourne Network’s ‘Connecting Women in Biotechnology Luncheon’ five years ago. It was from these humble beginnings that years later up to 400 women from the life sciences sector gather once a year to celeb... read more…
POLITICAL ALERT - CRCs The Perfect Partners For Innovation and Research
16th May, 2013Two Cooperative Research Centres (CRCs) have been awarded for the strength of their collaborative work in the fields of environmental contamination remediation and composite materials technology.
The CRC for Contamination Assessment and Remediation of the Environment (CRC CARE) and the CRC for Advanced Composite Structures (CRC-ACS) have been awarded 2013 CRC Star Awards.
Presen... read more…
Bionomics Presents Update on BNC101 at Leading US Antibody Conference
April 29 2013. Bionomics Limited (ASX: BNO) (ADR: BMICY) today announced that Dr Christopher Reyes, its Vice President of Research and Development Biologics, will provide an update on the BNC101 LGR5 cancer program and it’s CSC Rx Discovery™ platform at the 2013 PEGS “Promising New Targets – Oncology Stream” meeting in Boston, MA, USA.BNC101 entered Bionomics’ pipeline as a result of Bionomics... read more…
New ‘Superbug’ Antibiotic Approved for use in Australia
April 26 2013. An effective new antibiotic designed to specifically treat the common superbug* infection Clostridium difficile-associated diarrhoea will be available to patients in Australia from 14th May 2013.Melbourne biopharmaceutical company Specialised Therapeutics Australia Pty Ltd (STA) has received Therapeutic Goods Administration (TGA) approval to market the drug DIFICID (fidaxomicin)... read more…
2013 Melbourne Osaka Future Leaders Exchange Program
April 23 2013. This year marks the 35th Anniversary of Melbourne’s first sister city relationship with the City of Osaka.To mark this significant milestone The Rotary Club of Melbourne in conjunction with the City of Melbourne invites Melbourne professionals engaged in the biotech, pharma or life sciences sectors to apply to be part of a unique 10 day professional development program.The Melbo... read more…
Manufacture of BNC101 commences at Lonza
April 23 2013. Bionomics Limited (ASX: BNO) (ADR: BMICY) announced today that it has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies. Dr Deborah Rathjen, Bionomics CEO & Managing Director commented, "The start of manufacturing activities for BNC101 signals a significant step towards clinical trials. We ant... read more…
Phosphagenics’ Partner Themis Completes Supply Agreement with Novartis for TPM/Diclofenac Gel
April 16 2013. Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) today announced that its commercial partner, Themis Medicare Limited, made the following release to the Bombay Stock Exchange (BSE) post market on Friday 12 April. The release relates to the manufacture and supply of their specially formulated TPM/diclofenac gel to Novartis India Limited."... read more…
LBT enters in to exclusive discussions with European company for global commercialisation of diagnostic technology
April 15 2013. Medical technology company LBT Innovations Limited (ASX: LBT) has signed an agreement with the Switzerland-based laboratory instrumentation company, Hettich AG Switzerland, to finalise a partnership to complete the development and commercialisation of LBT’s Automated Plate Assessment System (APAS®).The agreement allows for exclusivity for one month while the two parties complete... read more…
Alchemia SPP Closes Heavily Oversubscribed
April 12 2013. Australian drug discovery and development company Alchemia Limited (ASX: ACL) (“Alchemia” or the “Company”) has successfully closed its share purchase plan (“SPP”) heavily oversubscribed.After scaling back demand, the Company has raised $2.75 million. This capital is in addition to the $10.2 million recently raised via an institutional placement. Following a scale back and round... read more…
Draft Pharmaceutical Patents Review Report Released
April 9 2013. DRAFT PHARMACEUTICAL PATENTS REVIEW REPORT RELEASED - BAD NEWS FOR RESEARCH BASED PHARMACEUTICAL INDUSTRY
By Michael Caine and Mark Roberts, Davies Collison Cave On 2 April 2013 the Pharmaceutical Patents Review Panel released its draft report for public comment. While the findings and recommendations in the Report are not unexpected, given the make up of the panel and the shor... read more…
Strategic Review of Health and Medical Research
April 5 2013. The Minister for Health, the Hon Tanya Plibersek MP, has today released the report of the McKeon Review - Strategic Review of Health and Medical Research – Better Health through Research.The full report can be accessed by clicking hereThe summary version of the report can be accessed by clicking hereReview of Health and Medical Research in AustraliaThe Strategic Review of Health ... read more…
Phosphagenics: Oxycodone Patch Resumes Clinical Development
April 5 2013. Australian drug delivery technology company, Phosphagenics Limited (ASX: POH, OTCQX: PPGNY), will be returning to the clinic with its oxycodone TPM® transdermal patch.The Company has received ethics approval to conduct a further clinical trial at the Royal Adelaide Hospital’s independent CMAX facility. The trial is designed to assess the profile of the new patch and form an integ... read more…
Up to $10 million in cancer research funding available through the Australian Cancer Research Foundation
April 3 2013. The Australian Cancer Research Foundation (ACRF) has begun accepting applications for their 2013 annual Cancer Research Grant Round.The ACRF provides major grants between $1.5 and $5 million to develop state-of-the-art, collaborative research centres and purchase advanced technologies and equipment.Grants of this magnitude are not available from any other private funding body in ... read more…
Phosphagenics Extends Agreement with Japanese Partner
April 2 2013. Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has extended its collaboration with its high calibre Japanese partner, Nippon Zoki Pharmaceutical Co., Ltd., to develop a new anti-inflammatory product to treat acute and chronic pain for the US market.The parties are progressing their collaboration arrangements to develop a more effective ... read more…
Allied Lodges 510(K) with FDA for CardioCel® Marketing Approval
April 2 2013. Allied Healthcare Group (ASX: AHZ) today announced that on the 29th of March, US time, the Company lodged its Premarket Notification 510(k) Submission for CardioCel® in the United States (U.S). The FDA 510(K) submission is a major step in Allied’s strategy to gain marketing approval for CardioCel® in the U.S.CardioCel® is a cardiovascular tissue patch used to repair heart deformi... read more…
Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of Treatments for Pain
March 29 2013. Spinifex Pharmaceuticals, an Australian pain drug development company, today announces it has received an approximately AUS$1.5 million R&D tax incentives cash refund for research activities relating to the discovery of new drugs for the treatment and management of pain. The R&D Incentive Program is an annual scheme, jointly administered by AusIndustry and the Australian Taxatio... read more…
Oxymorphone Patch Meets Phase 1 End Points
March 28 2013. Australian drug delivery technology company, Phosphagenics Limited (ASX: POH, OTCQX: PPGNY), advises that it has achieved all end points of its important Phase 1 trial of its oxymorphone patch by successfully delivering the powerful opioid into the bloodstream via its patented TPM® transdermal skin patch.The single dose Phase 1 study, conducted at the CMAX independent clinical r... read more…
Office of PM: Changes to the Ministry
March 25 2013. Today Gary Gray joins the Cabinet as Minister for Resources and Energy, Minister for Tourism and Minister for Small Business.
He has been a tireless advocate for business in his own community and in Western Australia and will bring that purpose to promoting the interests of the tourism sector and small business.
His current roles as Special Minister of State and Minister for t... read more…
Victorian Coalition Government Ministry
March 13 2013. Victorian Premier Denis Napthine has unveiled his new cabinet line-up after taking over from Ted Baillieu last week. Nationals leader and the deputy Premier Peter Ryan remains deputy Premier and the minister for Regional and Rural Development and State Development. Kim Wells, who was previously the Treasurer, now takes over police from Mr Ryan. Michael O'Brien now takes over as ... read more…
